Hikal Limited
Equibles does not estimate personal net worth.
Manoj Bhairotra has spoken on 2 earnings calls across 1 company, most recently for Hikal Limited on November 3, 2026. Hikal Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“For quarter 2 FY27, the pharma business reported revenue of Rs. 278 crores. EBIT of Rs. 13 crores and an EBIT margin of 4.6%. For H1 FY27, the pharmaceutical business reported revenue of Rs.”
“For FY26, pharma business reported revenue of Rs. 1021 crores and EBIT of Rs. 58 crores and EBIT margin of 5.7 percent. For Q4 FY26, farmer business reported revenue of Rs.”
Hikal Limited
Transcript header (unverified)
Hikal Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Hikal Limited
Earnings Call for the Quarter Ended March 31, 2026
Hikal Limited
